| scholarly article | Q13442814 |
| P2093 | author name string | Christer Jansson | |
| Alexandre Paccou | |||
| Bengt-Göran Osterdahl | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| P304 | page(s) | 5085-5088 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Journal of Agricultural and Food Chemistry | Q1024905 |
| P1476 | title | Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market | |
| P478 | volume | 52 |
| Q39756867 | A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015. |
| Q27497394 | A fresh look at tobacco harm reduction: the case for the electronic cigarette |
| Q55001844 | Alternative tobacco product use and smoking cessation: a national study. |
| Q37606703 | An epidemiologic review of smokeless tobacco health effects and harm reduction potential |
| Q42935481 | Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry |
| Q36558268 | Analysis of Tobacco-Specific Nitrosamines in the Common Smokeless Tobacco Afzal in Oman |
| Q42952162 | Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction? |
| Q45920250 | Are smokers receptive to using smokeless tobacco as a substitute? |
| Q92659297 | Chemical analysis of snus products from the United States and northern Europe |
| Q34018813 | Cigarettes and oral snuff use in Sweden: Prevalence and transitions |
| Q45996379 | Emerging nicotine delivery products. Implications for public health. |
| Q37461637 | Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco |
| Q90030118 | Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States |
| Q92192503 | Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus) |
| Q39407586 | Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers |
| Q36272841 | Health risks of smoking compared to Swedish snus |
| Q28831487 | High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus |
| Q53192694 | Inhibition by blueberries (bilberries) and extract from milk thistle of rat forestomach hyperplasia induced by oral smokeless tobacco (Swedish snus). |
| Q43153653 | Levels of toxins in oral tobacco products in the UK. |
| Q37423107 | Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. |
| Q37483927 | Maternal snuff use and smoking and the risk of oral cleft malformations--a population-based cohort study |
| Q33943746 | New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. |
| Q33593395 | Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden |
| Q34308718 | Nonsmokers' responses to new warning labels on smokeless tobacco and electronic cigarettes: an experimental study |
| Q37459141 | Patterns of co-morbidity of eating disorders and substance use in Swedish females |
| Q44010134 | Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population |
| Q45933615 | Quantitative method for analysis of tobacco-specific N-nitrosamines in mainstream cigarette smoke by using heart-cutting two-dimensional liquid chromatography with tandem mass spectrometry. |
| Q36930343 | Role of snus in initiation and cessation of tobacco smoking in Sweden. |
| Q30466682 | Role of tobacco use in the etiology of acoustic neuroma |
| Q64061339 | SLTChemDB: A database of chemical compounds present in Smokeless tobacco products |
| Q38977509 | Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts |
| Q80788942 | Smokeless tobacco use is associated with a substantial risk of oral cancers in India |
| Q24597926 | Snus use and other correlates of smoking cessation in the Swedish Twin Registry |
| Q80325086 | Snus--what should the public-health response be? |
| Q35747733 | Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series |
| Q37821539 | Summary of the epidemiological evidence relating snus to health. |
| Q48112602 | Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff. |
| Q34038743 | The STAGE cohort: a prospective study of tobacco use among Swedish twins |
| Q35978839 | The in vitro toxicology of Swedish snus |
| Q44975493 | The molecular basis for induction of human cancers by tobacco specific nitrosamines |
| Q46727658 | Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden |
| Q36408509 | Use of rodent data for cancer risk assessment of smokeless tobacco in the regulatory context |
| Q28276089 | Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis |
Search more.